tirzepatide class of drug Patients who took the anti-obesity for almost two years lost 25 percent their body weight and maintained improvements in metabolic and cardiovascular health, according to a new phase 3 Tirzepatide: A New Dual Receptor
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

























